- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01655316
Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control
PSVT is a common rhythm disorder in emergency department which can be recurrent in some cases.
Intravenous Adenosine is the drug of choice in PSVT control in acute settings but is a very short acting agent.
Providing a complementary medication to decrease the rate of recurrence of PSVT after its initial control will be promising.
This study evaluates the role of the oral Verapamil in recurrence control of PSVT in emergency situations.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age>18 years old
- PSVT on emergency department presentation
Exclusion Criteria:
- Instability in hemodynamic status
- Allergy to Verapamil
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Verapamil
40 mg Verapamil Per Oral
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Recurrence Control
Time Frame: 2 hours
|
2 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Arrhythmias, Cardiac
- Cardiac Conduction System Disease
- Tachycardia
- Tachycardia, Ventricular
- Tachycardia, Supraventricular
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Vasodilator Agents
- Membrane Transport Modulators
- Calcium-Regulating Hormones and Agents
- Calcium Channel Blockers
- Verapamil
Other Study ID Numbers
- 16062
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paroxysmal Supraventricular Tachycardia
-
Erasmus Medical CenterUnknownTachycardia, Supraventricular | Tachycardia; Paroxysmal, SupraventricularNetherlands
-
Milestone Pharmaceuticals Inc.Medpace, Inc.CompletedParoxysmal Supraventricular Tachycardia (PSVT)United States, Canada
-
Milestone Pharmaceuticals Inc.TerminatedParoxysmal Supraventricular Tachycardia (PSVT)United States
-
Milestone Pharmaceuticals Inc.RecruitingParoxysmal Supraventricular TachycardiaUnited States
-
Milestone Pharmaceuticals Inc.IQVIA BiotechCompletedParoxysmal Supraventricular TachycardiaUnited States, Argentina, Brazil, Canada, Colombia
-
Tongji HospitalFirst Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial People... and other collaboratorsUnknownParoxysmal Supraventricular TachycardiaChina
-
Medtronic Bakken Research CenterMedtronicCompleted
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.Milestone Pharmaceuticals Inc.RecruitingTachycardia, Supraventricular | Paroxysmal Supraventricular TachycardiaChina
-
Shanghai MicroPort EP MedTech Co., Ltd.Active, not recruitingParoxysmal Supraventricular TachycardiaChina
-
Yong Seog OhCompletedParoxysmal Supraventricular TachycardiaKorea, Republic of
Clinical Trials on Verapamil
-
Synerx Pharma, LLCCompleted
-
Bristol-Myers SquibbCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH)Completed
-
60 Degrees Pharmaceuticals LLCNot yet recruiting
-
Benjamin BleierTerminated
-
Medical University of GrazJuvenile Diabetes Research FoundationRecruitingDiabetes Mellitus, Type 1United Kingdom, Belgium, Poland, Austria, France, Germany, Italy
-
University Health Network, TorontoWithdrawn
-
Center Laboratories, Inc.TerminatedEpisodic Cluster HeadacheUnited Kingdom
-
AbbottCompletedHypertension | Diabetes